Evidence map›Paper›PMID 28045349›Full record

ArticlePsychiatric services (Washington, D.C.)2017

First Presentation With Psychotic Symptoms in a Population-Based Sample.

Gregory E Simon, Karen J Coleman, Bobbi Jo H Yarborough, Belinda Operskalski, Christine Stewart, Enid M Hunkeler, Frances Lynch, David Carrell, Arne Beck

Abstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gregory E SimonDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Karen J ColemanDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Bobbi Jo H YarboroughDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Belinda OperskalskiDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Christine StewartDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Enid M HunkelerDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Frances LynchDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
David CarrellDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.
Arne BeckDr. Simon, Ms. Operskalski, Dr. Stewart, and Dr. Carrell are with the Group Health Research Institute, Group Health Cooperative, Seattle (e-mail: simon.g@ghc.org ). Dr. Coleman is with the Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena. Dr. Yarborough and Dr. Lynch are with the Center for Health Research, Kaiser Permanente, Portland, Oregon. When this work was done, Ms. Hunkeler, who is now retired, was with the Division of Research, Kaiser Permanente, Oakland, California. Dr. Beck is with the Institute for Health Research, Kaiser Permanente of Colorado, Denver.

Funding

Precursors of first-episode psychosis in a population-based sampleR01MH099666 · NIMH · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI SIMON, GREGORY E. · 2013 to 2015
$2.2M
NIMH NIH HHS R01 MH099666
6 · The paper itself

Abstract

objectiveIncreasing evidence supports the effectiveness of comprehensive early intervention at first onset of psychotic symptoms. Implementation of early intervention programs will require population-based data on overall incidence of psychotic symptoms and on care settings of first presentation.

methodsIn five large health care systems, electronic health records data were used to identify all first occurrences of psychosis diagnoses among persons ages 15-59 between January 1, 2007, and December 31, 2013 (N=37,843). For a random sample of these putative cases (N=1,337), review of full-text medical records confirmed clinician documentation of psychotic symptoms and excluded those with documented prior diagnosis of or treatment for psychosis. Initial incidence rates (based on putative cases) and confirmation rates (from record reviews) were used to estimate true incidence according to age and setting of initial presentation.

resultsAnnual incidence estimates based on putative cases were 126 per 100,000 among those ages 15-29 and 107 per 100,000 among those ages 30-59. Rates of chart review confirmation ranged from 84% among those ages 15-29 diagnosed in emergency department or inpatient mental health settings to 19% among those ages 30-59 diagnosed in general medical outpatient settings. Estimated true incidence rates were 86 per 100,000 per year among those ages 15-29 and 46 per 100,000 among those ages 30-59.

conclusionsWhen all care settings were included, incidence of first-onset psychotic symptoms was higher than previous estimates based on surveys or inpatient data. Early intervention programs must accommodate frequent presentation after age 30 and presentation in outpatient settings, including primary care.

Indexed as

AdolescentAdultAffective Disorders, PsychoticCaliforniaColoradoElectronic Health RecordsFemaleHumansIncidenceMaleMiddle AgedNorthwestern United StatesPsychotic DisordersSchizophreniaYoung AdultEpidemiologyPsychosesSchizophrenia

Identifiers

PMID28045349
PMCPMC5811263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.